These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8339736)

  • 1. Localization of hepatic metastases by radiolabelled anti-carcinoembryonic antigen antibody and meta-iodobenzylguanidine in a patient with medullary thyroid carcinoma.
    Liewendahl K; Välimäki M; Taavitsainen M
    Eur J Nucl Med; 1993 Jun; 20(6):551-4. PubMed ID: 8339736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The evaluation of 123I-MIBG scintigraphy in medullary thyroid carcinoma (MTC)].
    Ahuja S; Koppenhagen K; Ernst H
    Strahlenther Onkol; 1990 Nov; 166(11):718-21. PubMed ID: 2260009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine.
    Sone T; Fukunaga M; Otsuka N; Morita R; Muranaka A; Yanagimoto S; Tomomitsu T; Nakayama H; Harada T
    J Nucl Med; 1985 Jun; 26(6):604-8. PubMed ID: 3158726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
    Behr TM; Gratz S; Markus PM; Dunn RM; Hüfner M; Schauer A; Fischer M; Munz DL; Becker H; Becker W
    Cancer; 1997 Dec; 80(12 Suppl):2436-57. PubMed ID: 9406695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
    Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y
    J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (131I)meta-iodobenzylguanidine scintigraphy and selective venous catheterization after thyroidectomy for medullary thyroid carcinoma.
    Lupoli G; Lombardi G; Panza N; Biondi B; Pacilio G; Lastoria S; Salvatore M
    Med Oncol Tumor Pharmacother; 1991; 8(1):7-13. PubMed ID: 2041383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The possible use of radioiodinated metaiodobenzylguanidine (MIBG) in medullary thyroid carcinoma.
    Troncone L; Rufini V; Maussier ML; Valenza V; Montemaggi P; Legnaioli M
    Thyroidology; 1988 Apr; (1):45-53. PubMed ID: 2484894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of medullary carcinoma of the thyroid with I-131 MIBG.
    Thomas CC; Cowan RJ; Albertson DA; Cooper MR
    Clin Nucl Med; 1994 Dec; 19(12):1066-8. PubMed ID: 7874804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine 131 metaiodobenzylguanidine scintigraphy of medullary carcinoma of the thyroid.
    Skowsky WR; Wilf LH
    South Med J; 1991 May; 84(5):636-41. PubMed ID: 1852077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Scintigraphy of medullary carcinoma of the thyroid by new radiopharmaceuticals].
    Tada J; Konishi J; Torizuka K; Makimoto K; Miyauchi A
    Rinsho Hoshasen; 1984 Sep; 29(9):1043-4. PubMed ID: 6096600
    [No Abstract]   [Full Text] [Related]  

  • 11. New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma.
    Hoefnagel CA; Delprat CC; Zanin D; van der Schoot JB
    Clin Nucl Med; 1988 Mar; 13(3):159-65. PubMed ID: 2838213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
    Clarke SE; Lazarus CR; Wraight P; Sampson C; Maisey MN
    J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.
    Hilditch TE; Connell JM; Elliot AT; Murray T; Reed NS
    J Nucl Med; 1986 Jul; 27(7):1150-3. PubMed ID: 3014086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of metastatic medullary thyroid cancer with 131I-MIBG scans in Sipple's syndrome.
    Itoh H; Sugie K; Toyooka S; Kawase M; Mukaino S; Hazama F; Endo K; Torizuka K; Nakao K; Imura H
    Eur J Nucl Med; 1986; 11(12):502-4. PubMed ID: 2874028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of metastatic medullary carcinoma of the thyroid with 131I-meta-iodobenzyl guanidine.
    Poston GJ; Thomas AM; Macdonald DW; Karvounaris D; Henderson BL; George P; Lynn JA; Lavender JP
    Nucl Med Commun; 1986 Apr; 7(4):215-21. PubMed ID: 2873544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and therapeutic potential of new radiopharmaceutical agents in medullary thyroid carcinoma.
    Troncone L; Rufini V; De Rosa G; Testa A
    Henry Ford Hosp Med J; 1989; 37(3-4):178-84. PubMed ID: 2576959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinoma.
    Verga U; Muratori F; Di Sacco G; Banfi F; Libroia A
    Henry Ford Hosp Med J; 1989; 37(3-4):175-7. PubMed ID: 2576958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The diagnosis of thyroid carcinoma].
    Sandrock D; Munz DL
    Dtsch Med Wochenschr; 1991 Jan; 116(2):77-8. PubMed ID: 1985815
    [No Abstract]   [Full Text] [Related]  

  • 19. Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer. A French cooperative study.
    Baulieu JL; Guilloteau D; Delisle MJ; Perdrisot R; Gardet P; Delépine N; Baulieu F; Dupont JL; Talbot JN; Coutris G
    Cancer; 1987 Nov; 60(9):2189-94. PubMed ID: 2894239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary-thyroid-carcinoma imaging in an animal model: use of radiolabeled anticalcitonin F(ab')2 and meta-iodobenzylguanidine.
    Guilloteau D; Baulieu JL; Besnard JC
    Eur J Nucl Med; 1985; 11(6-7):198-200. PubMed ID: 4076227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.